Page 48 - Annual Report
P. 48

The Academy’s Divisions / Initiatives 醫專支部/項目

            Editorial Board                                               編輯委員會
            The HKMJ Editorial Board currently has 7 Senior Editors and   目前,編輯委員會(編委會)包括七位高
            55 Editors and  Advisors. Each Senior Editor is responsible   級編輯和五十五位編輯及顧問。高級編
            for coordinating one of the various sections of the Journal.   輯各自統籌不同類型的醫學論文工作,
            The Editors nominate reviewers and make recommendations       編輯則負責提名同行評審人並對已提
            regarding the papers submitted.  The  Advisors lend their     交的論文作出建議,而顧問主要就論文
            professional expertise to provide statistical or methodological   的統計學或研究方法,以及管理期刊等
            guidance for submitted papers, or other aspects of journal    事宜提供專業意見。在總編輯領導下,
            management. Under the leadership of the Editor-in-Chief,      編委會為雜誌制定政策,決定送審或退
            the Editorial Board establishes and defines the policies of   稿,以及為作者、同行評審人和編輯部
            the Journal  makes editorial decisions  and formulates clear   人員制定清晰明確的指引,確保雜誌順
            guidelines for authors, reviewers, and the editorial office   利運作。編委會致力提高雜誌的質量和
            to ensure smooth operation of the Journal.  The Editorial     相關性,包括加快處理當前熱門話題之
            Board members are committed to enhancing the quality and      文章和嚴謹審查已提交文章的研究方
            relevance of the Journal by expediting articles on current    法。
            hot topics and applying rigorous methodological review of
            submitted articles.

            Improving Impact Factor                                       提升中的學術影響力
            The Hong Kong Academy of Medicine Press is delighted that     2024年科睿唯安期刊引證報告顯示,
            the 2023 Journal Impact Factor of the HKMJ is 3.1 (Clarivate   2023年《香港醫學雜誌 》的影響系數為
            Analytics, 2024), along with a notable rise from Quartile 2 to   3.1,在Medicine, General and Internal
            Quartile  1,  ranked  56  out  of  325  journals  under  “Medicine,   領域的三百二十五本期刊中位列第
            General and Internal” in the Journal Citation Report for      五十六位,並由Q2區升至Q1區(影響因
            “Medicine, General and Internal” (impact factor at top 17.1%).   子位列前17.1%)。醫專感謝編委會、作者
            Appreciation goes to all Editorial Board members, authors, and   和同行評審人的積極參與和貢獻。
            reviewers for their unwavering support.


            Prize for Best Original Paper Award (BOPA)                  《最佳原創論文獎》

            The award, presented by the Editorial Board of the Hong Kong   《香港醫學雜誌 》編輯委員會設立最佳
            Medical Journal, encourages high-quality original writing by   原創論文獎,旨在鼓勵醫生撰寫高質素
            doctors. The winners of the 2023 Prize for Best Original Paper   的原創文章。2023年得獎者包括馮寶姿
            Award were: Dr. Genevieve Po-Gee Fung and her team’s          醫生及其團隊,研究題目為「單胎妊娠
            research  ‘Neonatal  mortality  in  singleton  pregnancies:  a  20-  新生兒死亡率:香港公立醫院產科20年
            year retrospective study from a tertiary perinatal unit in Hong   回顧性研究」,以及郭子熹醫生及其團
            Kong’ and Dr. Carol Chi-Hei Kwok and her team’s research      隊,研究題目為「預防性使用粒細胞集
            ‘Effects of primary granulocyte-colony stimulating factor     落刺激因子對接受多西紫杉醇聯合環
            prophylaxis on neutropenic toxicity and chemotherapy dose     磷醯胺輔助化療的中國香港乳腺癌患
            delivery in Chinese patients with breast cancer who received   者的中性粒細胞毒性反應和化療劑量
            adjuvant docetaxel plus cyclophosphamide chemotherapy: a      的影響:回顧性隊列研究」。
            retrospective cohort study’.














     46          HKAM Annual Report 2024
   43   44   45   46   47   48   49   50   51   52   53